BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22987388)

  • 21. Plasma cell leukemia with ovarian serous cystadenocarcinoma.
    Rao PS; Shenoy KK; Rai S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):663. PubMed ID: 17883177
    [No Abstract]   [Full Text] [Related]  

  • 22. Rare form of extraovarian peritoneal serous papillary carcinoma with solitary tumor in the abdominal wall: a case report and literature review.
    Matsuura T; Sugihara K; Kohmura Y; Sugimura H; Kanayama N
    J Obstet Gynaecol Res; 2009 Dec; 35(6):1142-7. PubMed ID: 20144179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Examination by image analysis for determining quantitative DNA parameters of serous papillary adenocarcinoma of the endometrium--a single case analysis].
    Köhler U; Horn LG; Naumann G; Nenning H; Bilek K
    Zentralbl Gynakol; 1995; 117(4):213-6. PubMed ID: 7778358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
    Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
    Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage IV micropapillary serous ovarian carcinoma: a report of three cases.
    Kim YW; Srodon M; Bristow RE
    Int J Gynecol Pathol; 2005 Jul; 24(3):235-8. PubMed ID: 15968198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal disseminated recurrence and lung metastasis after surgery for stage IA uterine papillary serous carcinoma of the endometrium: a case report.
    Kanayama S; Yamada Y; Haruta S; Naruse K; Furukawa N; Kawaguchi R; Yoshida S; Sakata M; Sado T; Kitanaka T; Oi H; Kobayashi H
    Arch Gynecol Obstet; 2008 Sep; 278(3):277-80. PubMed ID: 18193438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ovarian thecoma associated with endometrial adenocarcinoma].
    Ferrara G; Tomaselli DE
    Minerva Ginecol; 1991 Jun; 43(6):311-4. PubMed ID: 1656328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
    Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
    Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case.
    Kaplan EJ; Caputo TA; Shen PU; Sassoon RI; Soslow RA
    Gynecol Oncol; 1998 Aug; 70(2):289-94. PubMed ID: 9740708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal implantations of papillary serous ovarian cystadenocarcinoma 13 days after initial laparoscopic treatment for a presumed benign ovarian cyst.
    Papoutsis D; Rodolakis A; Haidopoulos D; Sotiropoulou M; Antsaklis A
    Eur J Gynaecol Oncol; 2009; 30(1):103-5. PubMed ID: 19317271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
    Patsavas K; Woessner J; Gielda B; Rotmensch J; Yordan E; Bitterman P; Guirguis A
    Gynecol Oncol; 2011 Jun; 121(3):581-5. PubMed ID: 21440290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum.
    Hashi A; Yuminamochi T; Murata S; Iwamoto H; Honda T; Hoshi K
    Int J Gynecol Pathol; 2003 Oct; 22(4):374-7. PubMed ID: 14501819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of ovarian cancer management.
    Gaughan E; Javaid T; Cooley S; Byrne P; Gaughan G
    Ir Med J; 2006 Oct; 99(9):279-80. PubMed ID: 17144239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Papillary serous carcinoma of the uterus arising in an adenomyoma.
    Griffin M; Parai S; Ghatage P; Dimakulangan A
    Acta Cytol; 1996; 40(4):849-50. PubMed ID: 8693916
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage.
    Partheen K; Levan K; Osterberg L; Helou K; Horvath G
    Genes Chromosomes Cancer; 2004 Aug; 40(4):342-8. PubMed ID: 15188458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study.
    Zaino R; Whitney C; Brady MF; DeGeest K; Burger RA; Buller RE
    Gynecol Oncol; 2001 Nov; 83(2):355-62. PubMed ID: 11606097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations.
    Pisharodi LR; Bedrossian CW
    Diagn Cytopathol; 1996 Nov; 15(4):292-5. PubMed ID: 8982583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Squash cytodiagnosis of synchronous papillary serous carcinoma of ovary and endometrium with demonstration of serous tubal intraepithelial carcinoma as a precursor lesion.
    Kar A; Kar T; Dha I; Panda S
    Indian J Pathol Microbiol; 2017; 60(1):125-127. PubMed ID: 28195111
    [No Abstract]   [Full Text] [Related]  

  • 39. Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
    Trahan S; Têtu B; Raymond PE
    Hum Pathol; 2005 Dec; 36(12):1316-21. PubMed ID: 16311126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Borderline serous papillary tumor arising in a paraovarian cyst.
    Terada T
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):215-6. PubMed ID: 20188456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.